The US CDC and FDA have lifted their recommended pause on use of Johnson & Johnson's coronavirus vaccine with a condition that it will now include a safety label warning that its vaccine comes with blood clot risks.
J&J vaccination shots were paused last week after nine rare side effects were reported. Seven of the reactions were seen in women.
Five medical experts voted in a committee meeting on whether to lift pause on J&J covid-19 vaccine.
Two U.S. officials suggested that vaccine should come with warning about rare side effects.
Officials said the CDC is unlikely to recommend an age restriction on who can receive J&J vaccination, but some members wanted a warning for young women.
Dr Sarah Long, a Drexel University professor of pediatrics and one of committee members said, 'I think almost surely this is going to turn out to be related to the vaccine because of the clustering and because of the extraordinary, unusual presentation and findings of th...
Full Access
Included:
-
Access to All Articles.
-
One Plan. No Tiers.
-
No Ads.
-
Cancel anytime.
